Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pharmaceutical Fronts is Scopus-indexed (Q3, CiteScore 2.3), WoS ESCI, DOAJ. Published by Georg Thieme Verlag.
Checked against the index lists dated .
ISSN 2628-5088Verify ISSN ↗2628-5096Verify ISSN ↗
Publisher: Georg Thieme Verlag
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 113 / 191 | 41st | Q3 |
| Pharmacology (medical) | 177 / 278 | 36th | Q3 |
| Pharmacology | 237 / 328 | 27th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2020–present, best quartile Q3, CiteScore 2.3.
Pharmaceutical Fronts is Q3 in Pharmaceutical Science (rank 113 of 191), Q3 in Pharmacology (medical) (rank 177 of 278) and Q3 in Pharmacology (rank 237 of 328), by CiteScore 2025.
Pharmaceutical Fronts is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.3, which places it in quartile Q3 at the 41st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.292, quartile Q3, with an H-index of 9.
Pharmaceutical Fronts is published by Georg Thieme Verlag. Its print ISSN is 2628-5088 and its online ISSN is 2628-5096.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Pharmaceutical Fronts has an h-index of 13 and a 2-year mean of 1.19 citations per paper (OpenAlex). Its Scopus CiteScore is 2.3, quartile Q3. On 2-year citations it ranks #105 of 177 Scopus journals in Pharmaceutical Science.
Pharmaceutical Fronts published 35 papers in 2025; its busiest recent year was 2023 with 38. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2023–2026), authors are most often from China (85.7%), India (4.4%) and United Kingdom (1.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.